Supraglottis cancer
diseaseOn this page
Also known as cancer of supraglottic part of larynxmalignant neoplasm of extrinsic larynxmalignant neoplasm of supraglottic part of larynxmalignant neoplasm of supraglottismalignant neoplasm of the supraglottismalignant supraglottic neoplasmmalignant supraglottic part of larynx neoplasmmalignant supraglottic tumormalignant supraglottic tumourmalignant supraglottis neoplasmmalignant supraglottis tumormalignant supraglottis tumourmalignant tumor of supraglottismalignant tumor of the supraglottismalignant tumour of supraglottismalignant tumour of the supraglottissupraglottic part of larynx cancer
Summary
Supraglottis cancer (MONDO:0001724) is a cancer. A subtype of larynx cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | supraglottis cancer |
| Mondo ID | MONDO:0001724 |
| DOID | DOID:13476 |
| ICD-10-CM | C32.1 |
| NCIT | C3545 |
| SNOMED CT | 187842004 |
| UMLS | C0153484 |
| MedGen | 57561 |
| GARD | 0027590 |
| Anatomy (UBERON) | UBERON:0036263 |
| Is cancer (heuristic) | yes |
Also known as: cancer of supraglottic part of larynx · malignant neoplasm of extrinsic larynx · malignant neoplasm of supraglottic part of larynx · malignant neoplasm of supraglottis · malignant neoplasm of the supraglottis · malignant supraglottic neoplasm · malignant supraglottic part of larynx neoplasm · malignant supraglottic tumor · malignant supraglottic tumour · malignant supraglottis neoplasm · malignant supraglottis tumor · malignant supraglottis tumour · malignant tumor of supraglottis · malignant tumor of the supraglottis · malignant tumour of supraglottis · malignant tumour of the supraglottis · supraglottic part of larynx cancer
Disease family
This is a subtype of larynx cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › respiratory system cancer › larynx cancer › supraglottis cancer
Related subtypes (6): subglottis cancer, laryngeal cartilage cancer, glottis cancer, laryngeal carcinoma, laryngeal sarcoma, aryepiglottic fold cancer
Subtypes (1): carcinoma of supraglottis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.